Skip to main content

Series A · 2026-11-18 · AI

Boltz raises $110.0M

80
AI Score
Amount
$110.0M
Round
Series A
Lead
Bessemer Venture Partners
HQ
London, GB
Why it matters: Boltz's $110M Series A, led by Bessemer less than a year after leaving stealth, shows how quickly open-source protein-structure models are turning into funded drug-discovery platforms.

London-based AI drug discovery startup Boltz raised a $110M Series A led by Bessemer Venture Partners.

Participants:
Andreessen Horowitz, Amplify Partners, Zetta Venture Partners, Obvious Ventures, Greycroft, F-Prime Capital, Hummingbird, Benchling, Nvidia

Deal Dossier PRO

Pro feature
Deal Dossier for Boltz

Company, lead and participating investors, founders, and verified public contact channels — sourced, generated on demand.

Generate dossier — Pro
Already Pro? Sign in · See plans

Figures marked company-reported are unaudited. Not investment advice. Request a correction or removal (team@midu.si).

More deals with Bessemer Venture Partners

Recent AI rounds

Browse all deals in the funding database →

Subscribe to the newsletters

Free, by email. No account needed. Pick one or both.

No spam. Unsubscribe anytime by emailing team@midu.si. Want alerts and full data? Sign up free (separate from the newsletter). Privacy.

Not investment advice. Midu summarizes public reports and SEC filings for information only. · Free API · Pricing